The molecular pathophysiology of vascular anomalies: Genomic research

Vascular anomalies are congenital localized abnormalities that result from improper development and maintenance of the vasculature. The lesions of vascular anomalies vary in location, type, and clinical severity of the phenotype, and the current treatment options are often unsatisfactory. Most vascular anomalies are sporadic, but patterns of inheritance have been noted in some cases, making genetic analysis relevant. Developments in the field of genomics, including next-generation sequencing, have provided novel insights into the genetic and molecular pathophysiological mechanisms underlying vascular anomalies. These insights may pave the way for new approaches to molecular diagnosis and potential disease-specific therapies. This article provides an introduction to genetic testing for vascular anomalies and presents a brief summary of the etiology and genetics of vascular anomalies.

Keywords

Vascular anomalies - Genomic research - DNA sequencing - Next generation sequencing - Signaling pathway

Publication History

Received: 06 April 2020

Accepted: 30 April 2020

Article published online:
22 March 2022

• REFERENCES

• 1 Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412-22
• 2 Mulliken JB, Burrows PE, Fishman DJ. Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd ed.. New York: Oxford University Press; 2013
• 3 Greene AK, Goss JA. Vascular anomalies: from a clinicohistologic to a genetic framework. Plast Reconstr Surg 2018; 141: 709e-717e
• 4 Lee JW, Chung HY. Vascular anomalies of the head and neck: current overview. Arch Craniofac Surg 2018; 19: 243-7
• 5 Queisser A, Boon LM, Vikkula M. Etiology and genetics of congenital vascular lesions. Otolaryngol Clin North Am 2018; 51: 41-53
• 6 Collins FS, Morgan M, Patrinos A. The Human Genome Project: lessons from large-scale biology. Science 2003; 300: 286-90
• 7 Sohn J. Next generation sequencing and anti-cancer therapy. J Korean Med Assoc 2019; 62: 119-29
• 8 Koboldt DC, Steinberg KM, Larson DE. et al. The next-generation sequencing revolution and its impact on genomics. Cell 2013; 155: 27-38
• 9 Wetzel-Strong SE, Detter MR, Marchuk DA. The pathobiology of vascular malformations: insights from human and model organism genetics. J Pathol 2017; 241: 281-93
• 10 Adams DM. Practical genetic and biologic therapeutic considerations in vascular anomalies. Tech Vasc Interv Radiol 2019; 22: 100629
• 11 International Society for the Study of Vascular Anomalies (ISSVA). ISSVA classification of vascular anomalies [Internet]. Milwaukee, WI: ISSVA. c2018 [cited 2020 May 11]. Available from: issva.org/classification
• 12 North PE, Waner M, Brodsky MC. Are infantile hemangiomas of placental origin?. Ophthalmology 2002; 109: 633-4
• 13 Khan ZA, Boscolo E, Picard A. et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. Version 2. J Clin Invest 2008; 118: 2592-9
• 14 Jinnin M, Medici D, Park L. et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 2008; 14: 1236-46
• 15 Uebelhoer M, Boon LM, Vikkula M. Vascular anomalies: from genetics toward models for therapeutic trials. Cold Spring Harb Perspect Med 2012; 2: a009688
• 16 Nasseri E, Piram M, McCuaig CC. et al. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol 2014; 70: 75-9
• 17 Ayturk UM, Couto JA, Hann S. et al. Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma. Am J Hum Genet 2016; 98: 789-95
• 18 Groesser L, Peterhof E, Evert M. et al. BRAF and RAS mutations in sporadic and secondary pyogenic granuloma. J Invest Dermatol 2016; 136: 481-6
• 19 Lim YH, Bacchiocchi A, Qiu J. et al. GNA14 somatic mutation causes congenital and sporadic vascular tumors by MAPK activation. Am J Hum Genet 2016; 99: 443-50
• 20 Ji Y, Chen S, Yang K. et al. Kaposiform hemangioendothelioma: current knowledge and future perspectives. Orphanet J Rare Dis 2020; 15: 39
• 21 Lee JW, Chung HY. Capillary malformations (Portwine Stains) of the head and neck: natural history, investigations, laser, and surgical management. Otolaryngol Clin North Am 2018; 51: 197-211
• 22 Shirley MD, Tang H, Gallione CJ. et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 2013; 368: 1971-9
• 23 Couto JA, Ayturk UM, Konczyk DJ. et al. A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth. Angiogenesis 2017; 20: 303-6
• 24 Couto JA, Huang L, Vivero MP. et al. Endothelial cells from capillary malformations are enriched for somatic GNAQ mutations. Plast Reconstr Surg 2016; 137: 77e-82e
• 25 Eerola I, Boon LM, Mulliken JB. et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003; 73: 1240-9
• 26 Amyere M, Revencu N, Helaers R. et al. Germline loss-of-function mutations in EPHB4 cause a second form of Capillary Malformation-Arteriovenous Malformation (CMAVM2) deregulating RAS-MAPK signaling. Circulation 2017; 136: 1037-48
• 27 Cho BC, Kim JB, Lee JW. et al. Cervicofacial lymphatic malformations: a retrospective review of 40 cases. Arch Plast Surg 2016; 43: 10-8
• 28 Boscolo E, Coma S, Luks VL. et al. AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation. Angiogenesis 2015; 18: 151-62
• 29 Osborn AJ, Dickie P, Neilson DE. et al. Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations. Hum Mol Genet 2015; 24: 926-38
• 30 Park H, Kim JS, Park H. et al. Venous malformations of the head and neck: a retrospective review of 82 cases. Arch Plast Surg 2019; 46: 23-33
• 31 Uebelhoer M, Natynki M, Kangas J. et al. Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB. Hum Mol Genet 2013; 22: 3438-48
• 32 Couto JA, Vivero MP, Kozakewich HP. et al. A somatic MAP3K3 mutation is associated with verrucous venous malformation. Am J Hum Genet 2015; 96: 480-6
• 33 Brouillard P, Boon LM, Mulliken JB. et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (“glomangiomas”). Am J Hum Genet 2002; 70: 866-74
• 34 Soblet J, Kangas J, Natynki M. et al. Blue Rubber Bleb Nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations. J Invest Dermatol 2017; 137: 207-16
• 35 Cavalcanti DD, Kalani MY, Martirosyan NL. et al. Cerebral cavernous malformations: from genes to proteins to disease. J Neurosurg 2012; 116: 122-32
• 36 Kim JB, Lee JW, Choi KY. et al. Clinical characteristics of arteriovenous malformations of the head and neck. Dermatol Surg 2017; 43: 526-33
• 37 Couto JA, Huang AY, Konczyk DJ. et al. Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation. Am J Hum Genet 2017; 100: 546-54
• 38 Bayrak-Toydemir P, McDonald J, Akarsu N. et al. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 2006; 140: 2155-62
• 39 Cole SG, Begbie ME, Wallace GM. et al. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 2005; 42: 577-82
• 40 Sung HM, Chung HY, Lee SJ. et al. Clinical experience of the Klippel-Trenaunay syndrome. Arch Plast Surg 2015; 42: 552-8
• 41 Jacob AG, Driscoll DJ, Shaughnessy WJ. et al. Klippel-Trenaunay syndrome: spectrum and management. Mayo Clin Proc 1998; 73: 28-36
• 42 Luks VL, Kamitaki N, Vivero MP. et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 2015; 166: 1048-54
• 43 Mirzaa GM, Riviere JB, Dobyns WB. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet 2013; 163C: 122-30
• 44 Kurek KC, Luks VL, Ayturk UM. et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 2012; 90: 1108-15
• 45 Lindhurst MJ, Sapp JC, Teer JK. et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011; 365: 611-9
• 46 Amary MF, Damato S, Halai D. et al. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 2011; 43: 1262-5